✦ LIBER ✦

How to manage risk of macrovascular disease in patients with type II diabetes

✍ Scribed by Betteridge, D.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of Macrovascular Disease in P

✍ Abu-Lebdeh, Haitham S.; Hodge, David O.; Nguyen, Tu T. 📂 Article 📅 2001 🏛 Mayo Clinic 🌐 English ⚖ 83 KB

Audit: Do patients with type II diabetes

✍ Hassanein, Mohamed M; Finshwick, Helen; Taylor, Mike A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Joint and distinct risk factors associat

✍ Anna V. Ciardullo; M. Monica Daghio; Massimo Bevini; Gaetano Feltri; Doriano Nov 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 173 KB

Pharmacological treatment of diabetic pa

✍ T. Tkác 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 48 KB

Asymmetric dimethylarginine is associate

✍ Katarzyna Krzyzanowska; Friedrich Mittermayer; Walter Krugluger; Christoph Schna 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Homocysteine concentrations in patients

✍ Alan N. Elias; Steven Eng 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB